Lance Y Hsieh1, Austin W T Chiang2, Loan D Duong1, Chih-Chung Kuo3, Stephanie X Dong1, Ranjan Dohil4, Richard Kurten5, Nathan E Lewis2, Seema S Aceves6. 1. Department of Pediatrics, University of California, San Diego, La Jolla, Calif; Division of Allergy Immunology, University of California, San Diego, La Jolla, Calif. 2. Department of Pediatrics, University of California, San Diego, La Jolla, Calif; Department of Bioengineering, University of California, San Diego, La Jolla, Calif. 3. Department of Bioengineering, University of California, San Diego, La Jolla, Calif. 4. Department of Pediatrics, University of California, San Diego, La Jolla, Calif; Division of Gastroenterology, University of California, San Diego, La Jolla, Calif; Rady Children's Hospital San Diego, Calif, San Diego, Calif. 5. Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital Research Institute, Little Rock, Ark. 6. Department of Pediatrics, University of California, San Diego, La Jolla, Calif; Division of Allergy Immunology, University of California, San Diego, La Jolla, Calif; Rady Children's Hospital San Diego, Calif, San Diego, Calif; Department of Medicine, University of California, San Diego, La Jolla, Calif. Electronic address: saceves@health.ucsd.edu.
Abstract
BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. OBJECTIVE: Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. METHODS: We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. RESULTS: We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. CONCLUSION: Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and α-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE.
BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. OBJECTIVE: Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. METHODS: We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. RESULTS: We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. CONCLUSION: Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and α-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE.
Authors: Indroneal Banerjee; Katrina Carrion; Ricardo Serrano; Jeffrey Dyo; Roman Sasik; Sean Lund; Erik Willems; Seema Aceves; Rudolph Meili; Mark Mercola; Ju Chen; Alexander Zambon; Gary Hardiman; Taylor A Doherty; Stephan Lange; Juan C del Álamo; Vishal Nigam Journal: J Mol Cell Cardiol Date: 2014-11-13 Impact factor: 5.000
Authors: Monika A Kwiatek; Ikuo Hirano; Peter J Kahrilas; Jami Rothe; Daniel Luger; John E Pandolfino Journal: Gastroenterology Date: 2010-09-19 Impact factor: 22.682
Authors: Justin K Huang; Daniel E Carlin; Michael Ku Yu; Wei Zhang; Jason F Kreisberg; Pablo Tamayo; Trey Ideker Journal: Cell Syst Date: 2018-03-28 Impact factor: 10.304
Authors: Yuta Kasagi; Kara Dods; Joshua X Wang; Prasanna M Chandramouleeswaran; Alain J Benitez; Fiona Gambanga; Jonathan Kluger; Tokunbo Ashorobi; Jonathan Gross; John W Tobias; Andres J Klein-Szanto; Jonathan M Spergel; Antonella Cianferoni; Gary W Falk; Kelly A Whelan; Hiroshi Nakagawa; Amanda B Muir Journal: J Allergy Clin Immunol Date: 2018-12-20 Impact factor: 14.290
Authors: Damian Szklarczyk; Andrea Franceschini; Stefan Wyder; Kristoffer Forslund; Davide Heller; Jaime Huerta-Cepas; Milan Simonovic; Alexander Roth; Alberto Santos; Kalliopi P Tsafou; Michael Kuhn; Peer Bork; Lars J Jensen; Christian von Mering Journal: Nucleic Acids Res Date: 2014-10-28 Impact factor: 16.971
Authors: L D Duong; R Rawson; A Bezryadina; M C Manresa; R O Newbury; R Dohil; Z Liu; K Barrett; R Kurten; S S Aceves Journal: Mucosal Immunol Date: 2019-10-21 Impact factor: 7.313